MedTrace Logo

Evaluation of the Renal Congestion, Perfusion and Function Before and After Diuretic Treatment in the ICU

NCT03704844 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-05-01

No results posted yet for this study

Summary

Renal congestion is a pathological state that can lead to acute kidney failure. Furosemide is known to lower renal congestion by its diuretic effect.

The aim of this trial is to study the reversibility of kidney congestion under diuretic therapy and assess through echodoppler parameters if it can improve renal perfusion and function in congestive ICU patients.

It could in fine lead to a better identification of patients that could benefit from diuretic therapy in the ICU.

Conditions

  • Renal Congestion

Interventions

OTHER

non applicable

non applicable

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03704844 on ClinicalTrials.gov